Cubist Systematic Strategies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cubist Systematic Strategies’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$9.76M	Sell	97,400 -106,800	-52%	-$9.62M	0.05%	580
2025 Q2	$16.9M	Buy	204,200 +25,200	+14%	+$2.01M	0.08%	355
2025 Q1	$14.5M	Sell	179,000 -146,500	-45%	-$13.1M	0.09%	315
2024 Q4	$29.3M	Buy	325,500 +21,600	+7%	+$2.09M	0.18%	96
2024 Q3	$30M	Buy	303,900 +33,400	+12%	+$3.28M	0.18%	100
2024 Q2	$25.1M	Buy	270,500 +112,600	+71%	+$10.1M	0.17%	103
2024 Q1	$15M	Buy	+157,900	New	+$14.7M	0.09%	294

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Cubist Systematic Strategies's XBI Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 8,100 shares — an estimated $724K sold.

Cubist Systematic Strategies first reported a position in XBI in Q2 2024 and held it in 2 quarters. The position peaked at $1.12M in Q2 2024. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Cubist Systematic Strategies reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 8,100 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $724K.
Cubist Systematic Strategies first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and held it in 2 quarters.
Cubist Systematic Strategies's State Street SPDR S&P Biotech ETF position peaked at $1.12M in Q2 2024.
682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.